Aktis Oncology, Inc.
AKTS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002035832
In the last 90 days, Aktis Oncology, Inc. insiders filed 0 open-market purchases and 5 sales; 113 institutions reported holding it in 13F filings for Q2 2026, worth $1.10B in total; Soros Fund Management is the only superinvestor holding it.
Members of Congress who traded AKTS
No member of Congress has reported a trade in Aktis Oncology, Inc. since 2020.
Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.